An update on heart damage after recovering from COVID-19 | A new way to battle blood clots | Colchicine use & CAD

“The differences in the findings are extremely important,” one researcher said. 

The new treatment strategy shows significant potential. A full evaluation was published in Microsystems & Nanoengineering.

Researchers explored data from more than 11,000 patients.

Knowing when same-day discharge is the right choice—and when it isn’t—can be especially challenging for cardiologists and their care teams. 

Numerous recalls for ER metformin occurred in 2020. This is the first of 2021.

New research, published in ESC Heart Failure, details why heart failure patients are a high-risk group and will benefit from vaccination. 

“The key for the ultimate adoption of this new procedure will be further refinements of the technology to ensure reliability and safety," University of Virginia Health researchers explained.

CDC researchers are estimating that asymptomatic COVID-19 carriers account for at least half of all community transmissions. This includes carriers who never develop symptoms as well as those who later do.